Welcome to LookChem.com Sign In|Join Free
  • or
(S)-2-amino-3-(ethyl-phenyl-amino)-propan-1-ol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1048350-75-9

Post Buying Request

1048350-75-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1048350-75-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1048350-75-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,8,3,5 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1048350-75:
(9*1)+(8*0)+(7*4)+(6*8)+(5*3)+(4*5)+(3*0)+(2*7)+(1*5)=139
139 % 10 = 9
So 1048350-75-9 is a valid CAS Registry Number.

1048350-75-9Relevant academic research and scientific papers

Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists

Galley, Guido,Beurier, Angélica,Décoret, Guillaume,Goergler, Annick,Hutter, Roman,Mohr, Susanne,P?hler, Axel,Schmid, Philipp,Türck, Dietrich,Unger, Robert,Zbinden, Katrin Groebke,Hoener, Marius C.,Norcross, Roger D.

, p. 192 - 197 (2016/03/01)

2-Aminooxazolines were discovered as a novel structural class of TAAR1 ligands. Starting from a known adrenergic compound 1, structural modifications were made to obtain highly potent and selective TAAR1 ligands such as 12 (RO5166017), 18 (RO5256390), 36 (RO5203648), and 48 (RO5263397). These compounds exhibit drug-like physicochemical properties, have good oral bioavailability, and display in vivo activity in a variety of animal models relevant for psychiatric diseases and addiction.

Pharmaceutical combination

-

Page/Page column 14, (2015/10/05)

The present invention relates to a pharmaceutical combination for the treatment of schizophrenia and acute manic episodes associated with bipolar disorders, which comprises a compound which is active on a trace amine-associated receptor 1 (TAAR1 agonist)

PHARMACEUTICAL COMBINATION

-

, (2012/02/06)

The present invention relates to a pharmaceutical combination for the treatment of schizophrenia and acute manic episodes associated with bipolar disorders, which comprises a compound which is active on a trace amine-associated receptor 1 (TAAR1 agonist)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1048350-75-9